Invesco Pharmaceuticals ETF
PJP
90 hedge funds and large institutions have $66.9M invested in Invesco Pharmaceuticals ETF in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 25 increasing their positions, 20 reducing their positions, and 6 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 20
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
1% more funds holding
Funds holding: 89 → 90 (+1)
2% more capital invested
Capital invested by funds: $65.8M → $66.9M (+$1.09M)
0.03% less ownership
Funds ownership: 18.22% → 18.19% (-0.03%)
63% less call options, than puts
Call options by funds: $322K | Put options by funds: $869K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$1.05M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.01M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$823K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$698K |
| 5 |
Vontobel Holding
Zurich,
Switzerland
|
+$397K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
-$1.83M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$813K |
| 3 |
PAM
Peak Asset Management
Louisville,
Colorado
|
-$673K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$386K |
| 5 |
NFC
Northeast Financial Consultants
Westport,
Connecticut
|
-$351K |
PJP Hedge Fund Activity: Q2 2021 in Review
90 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q2 2021, worth a combined $66.9M — up 1.7% from $65.8M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new PJP positions and 6 closed out — a net gain of 1 holder — while 25 added to existing stakes and 20 trimmed.
The largest buyer was Bank of America, adding an estimated $1.05M. The largest seller was LPL Financial, cutting an estimated $1.83M.
- 90 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q2 2021, up from 89 in Q1 2021.
- Funds reported $66.9M of Invesco Pharmaceuticals ETF stock for Q2 2021, up 1.7% quarter-over-quarter.
- 7 funds opened new Invesco Pharmaceuticals ETF positions in Q2 2021 and 6 closed out, a net change of +1 holder.
- The largest Invesco Pharmaceuticals ETF buyer in Q2 2021 was Bank of America, an estimated $1.05M added.
- The largest Invesco Pharmaceuticals ETF seller in Q2 2021 was LPL Financial, an estimated $1.83M sold.
Based on aggregated 13F filings for Q2 2021.